Head-to-head · WeighScore
Oria Meds vs Renlo Health
The verdict
Renlo Health takes it — 79.7/100 to 63.6/100.
Renlo Health grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. One of the few programs whose headline is the actual monthly rate, with the prescribing physician and the dispensing pharmacy both named.
We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.
Factor by factor
The same six graded dimensions, side by side. See the methodology.
The numbers
| Metric | Oria Meds | Renlo Health |
|---|---|---|
| WeighScore | 63.6/100 | 79.7/100 |
| Grade | C | C+ |
| Scorecard rank | #276 | #41 |
| Semaglutide | $199/mo (first month $89; the three- and six-month plans both cost $209 a month) | $199/mo, billed monthly at every dose |
| Tirzepatide | $369/mo (first month $129; three months $316/mo, six months $299/mo) | $269/mo, billed monthly at every dose |
| Coverage | All 50 states | Not publicly listed |
| Brand-name access | Compounded only | Compounded only |
| Oral / sublingual | Injection only | Injection only |
Graded #276 · C
Strengths
- Names its dispensing pharmacy, PerfectRx, with a street address and a phone number
- Free shipping and interest-free installments are offered at checkout
- The intake's plan menu returned identical ladders in two different states, so the price is not being varied by geography in the states tested
- Coverage is stated as all 50 states, subject to provider availability
Where it loses points
- Neither semaglutide nor tirzepatide is named anywhere on the public site; the molecule first appears at step two of the intake, after name, email, phone and shipping address are collected
- The homepage sells “starting at $149” and “starting at $249” and neither figure appears in the intake in either state tested
- The semaglutide ladder is inverted: one month is $199 a month, three months and six months are both $209 a month
- $89 and $129 are first-month promotional rates; the standing rates are $199 and $369
- A second price table sits in the homepage script and renders nowhere, quoting a $329 tirzepatide figure the live intake contradicts
- Two different scarcity counters appear on consecutive checkout screens, and review turnaround is stated as 24 hours in one place and 48 in another
- No legal entity, state of organization or governing law is published, and no clinician or NPI is named
Graded #41 · C+
Strengths
- The headline is the real month-to-month rate — no prepay division and no commitment behind an asterisk
- A genuine all-in line: medication, injection supplies, provider evaluation, ongoing care, expedited shipping and unlimited care-team messaging, with no membership or consultation fees
- Names the prescribing physician, Dr. Sean Arora, MD, and the dispensing pharmacy, VialsRX
- Same price at every dose with a price-lock badge
- A four-month money-back guarantee, and cancel anytime with no fee
Where it loses points
- A struck-through $399 sits beside the price with no published basis — Renlo never says what it was, when it applied or to whom
- That strikethrough comes from a stylesheet rule rather than a struck-out element, so a markup-level check would report the page clean
- A comparison table headed "Most GLP-1 providers" quotes $270, $365 and $445 by dose while naming no provider and citing no source
- A site-wide $50 code means the advertised figure is not the first amount charged
- No lab protocol is published, and there is no oral or brand route
Also worth a look
Neither is our top-graded pick — CoreAge Rx leads the scorecard
Across all 544 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.
Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.